Industry Briefs: Apr. 30, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
AMRI has launched Smartsourcing sourcing options for its contract manufacturing and research services.
AstraZeneca and The Medicines Company have entered into a global development and commercialization pact and have agreed to copromote Brilinta (ticagrelor), for treating acute ischaemic heart disease, in the United States.
Baxter International has completed its purchase of Sigma International.
Cetero Research has reached a final resolution with FDA over studies the company conducted in its Houston, Texas, bioanalytical laboratory between Apr. 1, 2005 through June 15, 2010.
Covance and BML are expanding the companies’ jointly owned clinical-trial laboratory in Japan.
GlaxoSmithKline and the University of Nottingham are collaborating to create a Center of Excellence for sustainable chemistry.
Penn Pharma has invested in additional clinical and commercial packing capabilities.
Teva has settled its patent-infringement litigation with Mylan in regards to Teva’s wakefulness product Nuvigil (armodafinil).
Therapure has opened a custom biologics manufacturing facility.
People News
AMRI has appointed Saravanakumar Dhakshinamoorthy as director of in vitro biology. Dhakshinamoorthy will report to Takeshi Yura, senior director of AMRI’s Singapore division.
Watson Pharmaceuticals has announced changes in the company’s senior leadership.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
